|
![]() |
|
|
May 25, 2005,
8:59 a.m.
But it is possible to believe that the search for cures is a worthy endeavor while also believing that there should be legally enforced ethical limits on it. Making taxpayers finance research that kills human beings falls on the wrong side of the line.
Congressmen also referred to the possibility that America would lose its scientific and economic “edge” if the federal government did not subsidize this research. Our best researchers would move to other lands with more generous subsidies. This worry is, however, essentially incompatible with the fear that by not subsidizing the research, we are throwing away possible cures for diseases. If those cures are found in other countries, then it stands to reason that Americans will have access to them. Congressmen in favor of the bill piled another contradiction on top of these. They said that by keeping the research in America we could make sure it followed ethical norms. The major ethical norm here would seem to be an either/or matter: If you are not going to forswear subsidizing the killing of human beings for research purposes, then what ethical norms remain to be imposed? But if it is the case that restricting federal funding for the research will drive it overseas, why wouldn’t imposing ethical norms do the same thing? The moment a restriction began to have bite, the congressmen’s logic would militate against it. a sound moral principle here.” President Bush, four years ago, said that the federal government would fund research on stem-cell lines that had already been taken from human embryos. But he also said that he would not encourage the taking of human life by funding research involving the destruction of human embryos after that time. Bush’s critics say that this funding is inadequate, even though hundreds of shipments of stem-cell lines have gone out to researchers. The critics say that these lines are “contaminated” because they were developed with mouse feeder cells and therefore cannot be used in clinical trials on humans. This is incorrect (although Reuters reported it as fact). Mouse feeder cells have been involved in the development of FDA-approved drugs and devices for humans before. Besides, several lines developed without mouse feeder cells are eligible for funding under Bush’s policy. But even if the critics were correct about these points, it would not establish that the policy should be expanded. Bush is trying to defend a sound moral principle here. He has promised a veto of the bill. If senators consider the issue’s moral complexities more wisely than Rep. DeGette a big if, we recognize it won’t have to come to that. * * * YOU’RE NOT A SUBSCRIBER TO NATIONAL REVIEW? Sign up right now! It’s easy: Subscribe to National Review here, or to the digital version of the magazine here. You can even order a subscription as a gift: print or digital! |
|
||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||